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Volcanic ash activates the nlrP3 
inflammasome in Murine and human 
Macrophages
David E. Damby1,2*, Claire J. Horwell 3, Peter J. Baxter 4, Ulrich Kueppers1, Max Schnurr 5, 
Donald B. Dingwell1 and Peter Duewell 5*
1 Department of Earth and Environmental Sciences, Ludwig-Maximilians-Universität (LMU) München, Munich, Germany, 
2 Volcano Science Center, United States Geological Survey, Menlo Park, CA, Unites States, 3 Department of Earth Sciences, 
Institute of Hazard, Risk and Resilience, Durham University, Durham, United Kingdom, 4 Institute of Public Health, University 
of Cambridge, Cambridge, United Kingdom, 5 Division of Clinical Pharmacology, Medizinische Klinik und Poliklinik IV, Klinikum 
der Universität München, Munich, Germany
Volcanic ash is a heterogeneous mineral dust that is typically composed of a mixture of 
amorphous (glass) and crystalline (mineral) fragments. It commonly contains an abun-
dance of the crystalline silica (SiO2) polymorph cristobalite. Inhalation of crystalline silica 
can induce inflammation by stimulating the NLRP3 inflammasome, a cytosolic receptor 
complex that plays a critical role in driving inflammatory immune responses. Ingested 
material results in the assembly of NLRP3, ASC, and caspase-1 with subsequent 
secretion of the interleukin-1 family cytokine IL-1β. Previous toxicology work suggests 
that cristobalite-bearing volcanic ash is minimally reactive, calling into question the 
reactivity of volcanically derived crystalline silica, in general. In this study, we target 
the NLRP3 inflammasome as a crystalline silica responsive element to clarify volcanic 
cristobalite reactivity. We expose immortalized bone marrow-derived macrophages 
of genetically engineered mice and primary human peripheral blood mononuclear 
cells (PBMCs) to ash from the Soufrière Hills volcano as well as representative, pure-
phase samples of its primary componentry (volcanic glass, feldspar, cristobalite) and 
measure NLRP3 inflammasome activation. We demonstrate that respirable Soufrière 
Hills volcanic ash induces the activation of caspase-1 with subsequent release of 
mature IL-1β in a NLRP3 inflammasome-dependent manner. Macrophages deficient 
in NLRP3 inflammasome components are incapable of secreting IL-1β in response 
to volcanic ash ingestion. Cellular uptake induces lysosomal destabilization involving 
cysteine proteases. Furthermore, the response involves activation of mitochondrial 
stress pathways leading to the generation of reactive oxygen species. Considering 
ash componentry, cristobalite is the most reactive pure-phase with other components 
inducing only low-level IL-1β secretion. Inflammasome activation mediated by inhaled 
ash and its potential relevance in chronic pulmonary disease was further evidenced in 
PBMC using the NLRP3 small-molecule inhibitor CP-456,773 (CRID3, MCC950). Our 
data indicate the functional activation of the NLRP3 inflammasome by volcanic ash 
in murine and human macrophages in vitro. Cristobalite is identified as the apparent 
driver, thereby contesting previous assertions that chemical and structural imperfec-
tions may be sufficient to abrogate the reactivity of volcanically derived cristobalite. This 
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is a novel mechanism for the stimulation of a pro-inflammatory response by volcanic 
particulate and provides new insight regarding chronic exposure to environmentally 
occurring particles.
Keywords: inflammasome, nlrP3, reactive oxygen species, lysosomal damage, volcanic ash, cristobalite, silica, 
mineral dust
inTrODUcTiOn
Explosive volcanic eruptions generate vast plumes of ash. Their 
fall-out can affect extensive populated areas beyond the imme-
diate vicinity of a volcano. Ash is defined as the portion of the 
erupted ejecta less than 2 mm in diameter, and it is a heterogene-
ous mixture of glassy fragments, containing variable amounts of 
crystals and older rock from the volcanic edifice (lithics). Since 
the 1980 eruption of Mount St. Helens, USA, when ash impacted 
more than a million inhabitants in the Pacific Northwest, it has 
been known that a substantial fraction of the ejecta is of micron, 
or even sub-micron, size and, therefore, potentially capable of 
being a human respiratory health hazard (1).
An exacerbation of airway problems, such as asthma and 
chronic bronchitis, due to the heightened levels of fine particles 
in the ambient air suspended from the ash deposits, was an 
expected finding at Mount St. Helens (2). The presence of a 
significant amount of respirable crystalline silica, mainly as cris-
tobalite, however, was wholly unforeseen and has led to repeated 
toxicological testing of the ash to help establish the implications 
of ash exposure for human health [see review in reference (3)]. 
In particular, there was concern regarding the risks of developing 
silicosis in the general population and outdoor workers due to the 
established consequences of crystalline silica exposure, mainly as 
quartz, in industrial settings (4). The eruptions of the Soufrière 
Hills volcano on Montserrat, West Indies, starting in 1995 and 
lasting over 15 years, led to similar intensive study of the volcanic 
cristobalite hazard (3, 5). Ongoing work has constrained the pres-
ence of cristobalite in ash to eruptions that involve lava domes or 
incorporate pre-existing, altered flow-units (5, 6). This is because 
cristobalite forms by secondary mineralization or hydrothermal 
alteration in these environments and, therefore, is not present 
in primary magmatic ejecta. These discoveries have defined 
the environmental side of the hazard; however, the capacity of 
volcanic cristobalite to incite disease remains enigmatic (7, 8).
Previously, we have observed no systematic difference in 
reactivity when comparing ash containing crystalline silica, pre-
dominantly as cristobalite, and ash containing negligible amounts 
of crystalline silica (9, 10). Experimentally, cristobalite-bearing 
volcanic ash has incited granuloma formation in vivo (1, 11), but 
it is consistently less inflammatory and fibrogenic than would be 
expected for a crystalline silica-bearing dust (3, 12). However, we 
have recently reported on the propensity of volcanic ash to initiate 
an inflammatory immune response in vitro in macrophages (10). 
Crystalline silica in other mixed-mineral dusts is known to be 
variably reactive (13), whereby its pathogenicity may be altered 
by inherent structural and chemical defects along with effects 
imparted by other constituents in a mixed-phase dust; indeed, 
structural and chemical defects of volcanic cristobalite (which 
contains up to 3 wt.% aluminum) together with its presence in 
a heterogeneous dust have all been previously implicated in its 
reduced potency (8, 14, 15). The conflicting results to date have 
hindered efforts to provide health risk assessments (16), which 
consider all available evidence from in vitro and in vivo toxico-
logical tests. A mechanistic understanding of the hazard posed 
by volcanic ash is needed to resolve the existing conundrum and 
provide appropriate public health advice during future volcanic 
eruptions.
Inflammation plays a pivotal role in crystal-driven 
disease progression and can be observed in patients with 
particle-induced lung diseases (17). Although the exact 
mechanisms of how pathogenic particles drive inflamma-
tion is not completely understood, it has been shown that 
danger-associated molecular patterns, such as endogenous 
uric acid (gout) or cholesterol (atherosclerosis) as well as 
exogenous particles like asbestos (asbestosis) or crystalline 
silica (silicosis), share features of crystalline particles that 
activate the NLRP3 inflammasome (also known as CIAS1, 
NALP3, or cryopyrin) (18–20). The NLRP3 inflammasome 
belongs to the Nod-like receptor pyrin-containing family 
of cytosolic receptors and, together with the adapter mol-
ecule apoptosis-associated speck-like protein containing 
a CARD domain (ASC), it forms a multi-protein platform 
that recruits and activates caspase-1. Caspase-1 belongs to 
the inflammatory caspases and leads to the processing and 
secretion of the pro-inflammatory cytokines interleukin-1 
beta (IL-1β) and IL-18 into their active forms (21). While 
the exact upstream mechanism of NLRP3 activation remains 
unclear and is part of ongoing studies, the current under-
standing of NLRP3 inflammasome assembly mainly consists 
of a two-hit mechanism. NLRP3, as well as the pro-form of 
IL-1β, is not constitutively expressed and needs transcrip-
tional priming. The first step in activation can be achieved 
by the germ line-encoded TLRs that usually sense microbial 
cell wall components or viral DNA and RNA molecules. The 
NLRP3 inflammasome senses crystalline danger signals that 
can occur during autoinflammatory diseases, such as gout or 
atherosclerosis, and environmental diseases, such as silicosis 
or asbestosis (18, 20, 22). IL-1 cytokines are potent mediators 
of innate immunity in response to crystalline silica exposure 
(23, 24) and have been implicated in the pathophysiology of 
human and experimental diseases (25, 26).
Here, we report on the propensity of volcanic cristobalite to 
activate the NLRP3 inflammasome, in the wake of a series of in-
conclusive toxicological investigations of ash from recent major 
eruptions. The NLRP3 inflammasome has emerged as a central 
mechanism in mediating cellular responses to various endo- 
and exogenous signals and particles related to environmental 
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and life-style diseases. Given the established hazard posed by 
respirable crystalline silica in occupational settings, the capac-
ity of volcanic ash to stimulate IL-1β release by macrophages 
in  vitro (10), and the observation that instigation of chronic 
disease by crystalline silica is NLRP3-dependent (27, 28), we 
have chosen to test the ability of cristobalite-bearing volcanic 
ash to promote inflammation by activating the inflammasome 
pathway.
MaTerials anD MeThODs
Volcanic ash sample and Major 
component control Particles
Ash sample MRA5/6/99 is a respirable sample isolated from 
fresh ash that fell at Soufrière Hills volcano, Montserrat, on 5 
June 1999. The ash was generated during a dome-collapse event, 
a particular style of eruption known to produce fine-grained, 
cristobalite-rich ash (5, 29). The respirable fraction was isolated 
using the Minisplit classification system at 16,000 rpm (British 
Rema, Sheffield, UK), which segregates particles within a vortex. 
The bulk tephra (sieved to 1 mm) was first separated to give a 
sub-10 μm fraction, and this fraction was further separated to 
give the sub-4 μm fraction. Sample MRA5/6/99 has been used 
extensively in ash characterization and toxicity studies; the ash 
is characterized in detail by Horwell et al. (29) and the crystal-
lographic properties of the cristobalite it contains by Damby et al. 
(14). The sample comprises ~15 wt.% crystalline silica as cris-
tobalite, with the other major constituents being volcanic glass 
(amorphous silica) and plagioclase feldspar; additional minor 
phases identified were hornblende, orthopyroxene, titanomag-
netite, and oxides (10, 29).
Pure-phase mineral samples of the primary components were 
analyzed alongside MRA5/6/99 to constrain their reactivity in the 
NLRP3 inflammasome model. Cristobalite was synthesized by 
heating ultra-high purity quartz glass (Heraeus HOMOSIL® 101, 
Hanau, Germany) for 12 h in a platinum crucible at 1,600°C in air. 
As a representative feldspar, we sourced labradorite (feldspar), an 
intermediate member of the plagioclase series, from the Bavarian 
State Collection for Mineralogy (Munich, Germany). Anhydrous 
andesite glass was produced from high temperature (1,450°C) 
melting of a sub-sample of Soufrière Hills pumice (described 
below) in a Nabertherm HI 04/17 furnace (Lilienthal, Germany) 
in air for 12 h. The sample was then stirred under similar con-
ditions in a second furnace to ensure a homogenous melt and 
rapidly quenched to produce glass. A cristobalite-free pumice 
sample from the 12 July 2003 eruption of Soufrière Hills volcano 
was included as the mineralogy is similar to MRA5/6/99, and 
it thus serves as a natural material control for the minor phases 
identified above [see reference (30)]. All componentry samples 
were ground dry in a mortar and pestle prior to use.
sample characterization
The particle size distributions of the samples were measured 
using a Coulter LS 230 Analyzer (Beckman Coulter Inc., CA, 
USA). Data were collected using the following refractive indices: 
1.63 for Soufrière Hills ash, as optimized in Horwell (31), 1.49 
for crystalline silica, 1.56 for feldspar, and 1.53 for synthetic 
andesitic glass (32). Data are the average of three 60-s runs and 
are analyzed according to the Mie scattering theory. The surface 
area of sample MRA5/6/99 is 3.6 m2/g as measured by the BET 
method of nitrogen adsorption (33).
Imaging of the volcanic ash sample was carried out on a Hitachi 
SU-70 FE-SEM (Hitachi, Ltd., Tokyo, Japan) in the GJ Russell 
Microscopy Facility, Department of Physics, Durham University. 
Images were collected at an operating voltage of 6.0  kV and a 
working distance of 14 mm. Sample mineralogy was confirmed 
by powder X-ray diffraction on a Bruker AXS D8 ADVANCE 
(Bruker Corp., MA, USA) with DAVINCI design in 2θ reflection 
mode using Cu radiation and a Ni filter in the Department of 
Chemistry, Durham University.
cell lines and reagents
Wild-type and knock-out bone marrow-derived immortalized 
mouse macrophage cell lines (iMΦ) were generated with a recom-
binant retrovirus, carrying v-myc and v-raf(mil) oncogenes, as 
previously described by Hornung et al. (22). Cells were cultured 
in DMEM supplemented with l-glutamine, 10% FCS (all Gibco, 
Darmstadt, Germany) and ciprofloxacin (Sigma, Taufkirchen, 
Germany). Freshly isolated human peripheral blood mononuclear 
cells (PBMCs) from randomly selected donors were obtained 
using density gradient centrifugation with subsequent red blood 
cell lysis. Cells were kept and stimulated in RPMI supplemented 
with l-glutamine, 10% FCS (all Gibco, Darmstadt, Germany) and 
ciprofloxacin (Sigma, Taufkirchen, Germany). iMΦ were seeded 
at a density of 1 ×  105 cells/96 well and PBMC at a density of 
1 × 106 cells/96 well and primed with 200 ng/ml (iMΦ) or 100 pg/
ml (PBMC) lipopolysaccharide (LPS, InvivoGen, Toulouse, 
France) for 2  h. For inhibitor studies, latrunculin A (Lat A), 
CA-074-ME, (2R,4R)-4-aminopyrrolidine-2,4-dicarboxylic acid 
(APDC), and CP-456,773 (CRID3, MCC950) were used at 20 µM 
and applied 1 h prior to stimulation. Cells were then stimulated 
with ash and componentry samples as indicated or with 5 mM 
adenosine triphosphate (ATP), 200  ng/ml polydeoxyadenylic 
acid • polythymidylic acid (dAdT), 10 µM nigericin (all Sigma 
Aldrich, Taufkirchen, Germany), or 1  mM H-Leu-Leu-OMe 
Hydrochloride (Santa Cruz, Heidelberg, Germany). After 6  h, 
IL-1α, IL-1β, IL-6, and TNFα cytokine levels in supernatants were 
measured by ELISA (all BD Biosciences, Heidelberg, Germany) 
or for supernatants and cell lysates with western blot analysis.
Western Blot
Immortalized macrophages and human PBMC were seeded 
and stimulated, as described above, but in serum-free media. 
Supernatants were removed and processed for protein precipita-
tion. Briefly, equivalent amounts of methanol and 20 vol.% chlo-
roform were added to supernatants, vortexed, and centrifuged 
at 12k rcf for 5 min. The top aqueous layer was discarded and 
methanol was added to remove remaining chloroform from 
precipitated whole-protein pellets. Samples were centrifuged at 
12k rcf for 5 min, supernatants were carefully removed and the 
protein pellets were air-dried. Precipitates were resolubilized 
in Lämmli buffer and heated at 95°C for 5  min. Samples were 
separated using SDS-PAGE and blotted for protein detection. 
FigUre 1 | Characteristics of isolated volcanic ash and pure-phase componentry. (a) Cumulative particle size distributions of volcanic ash sample MRA5/6/99 and 
componentry samples. (B) Particle size distribution and SEM image of volcanic ash sample MRA5/6/99 (×4.00k magnification). All particle size data are the average 
of three runs. (c) False-color backscatter SEM image of ash in cross section (×10k magnification) evidencing the heterogeneous distribution of predominant phases: 
cristobalite, feldspar, and volcanic glass. Electron dispersive X-ray spectroscopy was employed for mineral identification. Images were collected at 8.0 kV and a 
14.5 mm working distance.
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Membranes were blocked with 3% BSA and incubated with goat 
anti-mouse caspase-1 p20 (Santa Cruz, Heidelberg, Germany), 
goat anti-mouse IL-1β, or goat anti-human IL-1β (all R&D 
Systems, Wiesbaden-Nordenstadt, Germany) pAb overnight. 
HRP-coupled donkey anti-goat IgG secondary antibodies were 
incubated for 2 h. HRP-coupled β-actin IgG mAb served as load-
ing control.
light Microscopy
iMΦ were treated with 500 µg/ml volcanic ash for 6 h. Particle-
treated cells were imaged by light microscopy using a Zeiss 
Axiovert 200 M microscope (Zeiss, Oberkochen, Germany). Cell 
images were acquired using a 20× objective.
confocal laser reflection and immune 
Fluorescence imaging
iMΦ were seeded in glass-bottom dishes (Thermo Scientific, 
Darmstadt, Germany) at a density of 1 × 105 cells/ml in complete 
DMEM and allowed to adhere. Cells were incubated with the 
quenching dye conjugate DQ-Ovalbumin (DQ-OVA) in the 
presence or absence of MRA5/6/99 for 4 h. Cells were washed and 
counterstained with the membrane dye Alexa Fluor® 647-conju-
gated cholera toxin B subunit (Ctx B) and the nucleic acid stain 
Hoechst 33342 (Invitrogen, Karlsruhe, Germany). Combined 
reflection and immune fluorescence data were acquired using a 
Leica TCS SP5 AOBS confocal laser scanning microscope with 
63× magnification (Wetzlar, Germany).
statistical analysis
All results are expressed as mean ± SD. Comparisons and signifi-
cance between two groups was assessed by Student’s t-test. The 
level of significance is assigned to p ≤ 0.05.
resUlTs
Processing of Volcanic ash by Macrophages
Macrophages are a first line of defense against inhaled particles 
and are responsible for coordinating an inflammatory immune 
response. Therefore, they are key targets for in vitro assessment 
of the hazard posed by atmospheric particles. Diverse crystalline 
material has been reported to activate the NLRP3 inflamma-
some via phagosomal destabilization with lysosomal content 
leaking into the cytosol. Consequently, this leads to activation 
of a plethora of endoproteases and oxidative stress molecules by 
a not yet completely understood mechanism (22, 34). However, 
particle size is known to be important for entering the endosomal 
compartment, as reported for silica crystals with an average size 
of 1–2 µm (22). Volcanic ash comprises a wide range of particle 
sizes depending on the fragmentation efficiency of the eruption 
(35), but can contain a substantial respirable component (31). To 
represent pulmonary exposures, we used an isolated respirable ash 
sample, obtained through fractioning and sieving methods previ-
ously described (29), that derived from a dome-collapse event 
at Soufrière Hills volcano (MRA5/6/99) and synthetic particles 
of its corresponding componentry (Figure 1A). The ash sample 
FigUre 2 | Volcanic ash does not induce a primary inflammatory response. 
Lipopolysaccharide (LPS)-primed and unprimed wild-type murine 
macrophages were stimulated with volcanic ash sample MRA5/6/99 or 
nigericin and (a) TNFα and (B) IL-6 from supernatants were examined by 
ELISA. Representative data from two independent experiments are shown.
FigUre 3 | Volcanic ash-induced IL-1β production is NLRP3 inflammasome dependent. Lipopolysaccharide (LPS)-primed macrophages from wild-type or 
knock-out mice (NLRP3−/−, ASC−/−, and Casp-1/11−/−) were stimulated with MRA5/6/99 at indicated concentrations. (a) IL-1β from supernatants (SN) was 
measured with ELISA. (B) Mature IL-1β (p17) inSN and pro-IL-1β (p35) from cell lysates (CL) of cells stimulated with 1 mg/ml MRA5/6/99 was assessed by western 
blot. β-actin IgG mAb served as loading control. (c,D) Primary human peripheral blood mononuclear cells (PBMC) were either LPS-primed or left untreated and 
subsequently stimulated with MRA5/6/99. (c) IL-1α and (D) IL-1β levels in SN were determined by ELISA. Insertion (D) shows the western blot of bioactive IL-1β 
(p17) detected from SN. (e,F) IL-1α and IL-1β in SN of ash-treated human PBMC in the presence or absence of the NLRP3 inhibitor CP-456,773, assessed by 
ELISA. Positive controls are poly(dAdT), as a NLRP3-independent inducer, and adenosine triphosphate (ATP) or nigericin, as NLRP3-dependent inducers of IL-1β. 
Representative data from two independent experiments performed as triplicates are shown. (a) *p ≤ 0.05, compared to NLRP3−/−, ASC−/−, Caspase-1−/−; #p ≤ 0.05, 
compared to NLRP3−/− and ASC−/−; (c,D) *p ≤ 0.05, compared to none (Ø); (e,F) *p ≤ 0.05, compared to inhibitor (CP-456,773).
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is particularly fine-grained: scanning electron microscopy and 
particle sizing data of the isolated sample show that the particles 
are <5 µm, with a mode of 2 µm (Figure 1B). Backscatter SEM 
imaging reveals a heterogeneous distribution of volcanic glass, 
feldspar, and cristobalite as the predominant phases (Figure 1C). 
The ash sample has been previously reported to be successfully 
internalized by differentiated THP-1 cells, the human monocytic 
cell line (10).
Volcanic ash induces inflammation and 
leads to il-1β secretion
The inhalation and deposition of particulate pollutants, such 
as diesel exhaust, asbestos, or silica, in the small airways is 
known to induce inflammatory responses leading to sustained 
inflammation, lung fibrosis, and cancer (22, 25). The abundance 
of cristobalite in ash from Soufrière Hills volcano, as well as in 
ash from a large number of other dome-forming volcanoes [see 
(7) and references therein], and the potential for ash to induce 
the secretion of inflammatory cytokines prompted us to test the 
inflammatory response to ash particles further. Accordingly, we 
treated mouse macrophages with ash sample MRA5/6/99 and 
determined levels of TNFα, IL-6 and IL-1β in culture superna-
tants (Figures 2 and 3A). As expected, cells responded normally 
to the microbial TLR4 agonist LPS with high levels of TNFα and 
IL-6; however, no relevant cytokine secretion was detectable 
after exposure to volcanic ash without prior LPS stimulation 
(Figures  2 and 3A). Compared to other pro-inflammatory 
cytokines, pro-IL-1β lacks a signaling peptide sequence to 
exit the cell via golgi translocation. IL-1β is not constitutively 
expressed and requires transcriptional upregulation in response 
to a canonical NF-κB pathway or microbial stimuli, such as LPS, 
sensed by TLR receptors. As IL-1β itself is predominantly acti-
vated in a NLRP3/caspase-1-dependent manner, we investigated 
the involvement of the NLRP3 inflammasome in the response to 
volcanic ash.
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Volcanic ash-induced il-1β secretion 
involves the nlrP3 inflammasome and 
caspase-1 activation
Activation of the NLRP3 inflammasome results in assembly 
with the adaptor protein apoptosis-associated speck-like 
protein containing a CARD (ASC) and subsequent activation 
of caspase-1, with the release of active IL-1β. We stimulated 
immortalized wild-type macrophages or cells with deficiencies 
in the inflammasome signaling components NLRP3, ASC, 
or Caspase-1/11 with LPS (TLR4 ligand) and subsequently 
incubated the cells with volcanic ash sample MRA5/6/99 
(Figure  3A). Only LPS-primed macrophages responded with 
high amounts of IL-1β, pointing toward the involvement of 
the NLRP3 inflammasome. Analysis of supernatants revealed 
a strong and dose-dependent secretion of IL-1β from wild-type 
macrophages whereas cells with defects in NLRP3 signaling 
(NLRP3−/−, ASC−/−, and Caspase-1/11−/−) components failed to 
secrete IL-1β in response to volcanic ash exposure (Figure 3A). 
As control served the double-stranded DNA mimic dAdT 
that signals NLRP3 independently via the DNA sensor absent 
in melanoma 2 (AIM2), still requiring the adapter molecule 
ASC as well as caspase-1 for the processing of IL-1β (36). ATP 
signaling via the ligand-gated cation channel P2×7 served as 
the NLRP3-dependent positive control. To further confirm pro-
teolytic cleavage of IL-1β into its active form (p17 subunit), we 
performed a western blot analysis of whole cell lysates and the 
corresponding supernatants. As expected, volcanic ash was able 
to induce activation of mature IL-1β, however, in a moderate 
way compared to the positive control nigericin, a highly potent 
pore-forming toxin (Figure 3B).
We further analyzed the ash-induced release of IL-1 
family cytokines (IL-1α and IL-1β) from freshly isolated 
primary human PBMCs (Figures 3C–E). The closely related 
homolog IL-1α is, in contrast to IL-1β, biologically active, 
although little is known about its activation and secretion. 
IL-1α represents a key alarmin from dying cells and plays 
a pivotal role in acute particle-induced lung inflammation 
(37). Here, we show that volcanic ash samples alone are not 
capable of inducing IL-1 secretion in the absence of LPS 
priming. In contrast, LPS-activated PBMCs secreted high 
amounts of IL-1α and IL-1β in a dose-dependent manner 
(Figure 3C). Secretion of bioactive IL-1β again was assessed 
by western blot showing the cleaved p17 fragment in super-
natants of ash- or nigericin-treated samples (Figure  3D). 
Finally, the contribution of the NLRP3 inflammasome was 
confirmed using the specific NLRP3 inflammasome inhibitor 
CP-456,773 (CRID3, MCC950) that has been described earlier 
(38). The data show that CP-456,773 potently inhibited the 
release of IL-1β and, to a lesser extent, IL-1α (Figures 3E,F). 
Despite the well-described functions of IL-1β, IL-1α exists in 
two different forms, surface-bound pro-IL-1α and a mature 
secreted form. The fact that IL-1α can, on one hand, signal 
independently of inflammasome activation but, on the other 
hand, requires caspase-1 and mature IL-1β for secretion sug-
gests the involvement of other inflammatory pathways, which 
are yet to be exactly investigated (39).
cristobalite is the apparent Driver of il-1β 
secretion by Volcanic ash
Volcanic ash is a heterogeneous dust, the componentry of which 
can vary substantially amongst eruptions and even within the 
same eruption. Therefore, identifying the phase(s) responsible 
for the observed reactivity is critical for hazard assessment in 
the event of an eruption, where ash componentry analysis is a 
first priority in rapid-response efforts (9, 40). Despite the fact 
that all of the mineral phases present in volcanic ash are not bio-
soluble on the timescale of our experiments, or on the expected 
timescale of phagocytosis in vivo, physiologically relevant cations 
(K+, Na+, Ca2+) could be leached from the glass component via 
intra-cellular processing of particles in a matter of hours to days 
(41) by lysosomal fluid, a buffered, acidic (pH 5.5) solution largely 
comprising citric acid (42). This may augment the intra- and 
extra-cellular cation budget, an established condition implicated 
in inflammasome assembly and activation (43, 44). As neither 
the compositionally equivalent glass sample nor pumice, which is 
predominantly composed of glass, were comparably reactive, we 
discount particle alteration and glass leaching as primary controls 
on NLRP3 and subsequent caspase-1 activation by volcanic ash. 
This conclusion is substantiated by minimal (and equivalent) 
extraction of K+ and Na+ in leaching experiments conducted 
in dilute citric acid, the primary organic ligand in lysosomal 
fluid, and at a relevant pH (41). Therefore, we do not expect any 
significant alteration to the bulk phase assemblage throughout 
the experimental exposures, and contend that single-phase expo-
sures are appropriate to probe the reactivity of the mixed-phase 
volcanic ash.
Of the componentry samples, the silica compound cristo-
balite triggered the strongest dose-dependent release of IL-1β 
(Figure 4A), suggesting it is the predominant driver behind pro-
duction of IL-1β by volcanic ash. This aligns with the established 
propensity of cristobalite to induce production of IL-1β through 
activation of the NLRP3 inflammasome (45). We note, however, 
that intermediate levels of IL-1β were detected as well as the active 
caspase-1 subunit p20 in response to treatment of LPS-primed 
macrophages by all componentry samples (Figures  4B,C), 
thereby strengthening the evidence of NLRP3 involvement.
Volcanic ash acts through Translocation 
into the cytosol via lysosomal Disruption 
and reactive Oxygen species (rOs) 
Production
To demonstrate that volcanic ash was internalized by macrophages, 
we incubated immortalized macrophages with the isolated ash 
sample for 4 h and imaged untreated and particle-treated cells 
by light microscopy (Figure 5A). The material was taken up by 
the cells, resulting in massive clustering of particles within the 
cell, and the intensity of optical refraction (darker cells) illustrates 
the capacity of the macrophages in particle clearance. This aligns 
with other recent observations of successful phagocytosis of 
volcanic ash by macrophages with little associated decrease in 
cell viability (10, 46). We next combined confocal laser reflection 
and fluorescence imaging to further consider cellular uptake of 
FigUre 4 | Cristobalite is the main component for volcanic ash-induced IL-1β release. Lipopolysaccharide (LPS)-primed and unprimed wild-type murine 
macrophages were stimulated with the major ash components (feldspar, volcanic glass, and cristobalite) and natural crushed pumice sample at indicated 
concentrations. (a) IL-1β from supernatants (SN) was examined by ELISA and (B) assessment of mature IL-1β (p17) from SN of LPS-primed macrophages by 
western blot. (c) Activated caspase-1 (p20 subunit) in supernatant detected by western blot analysis. Representative data from two independent experiments 
performed as triplicates are shown. *p ≤ 0.05, compared to other components; #p ≤ 0.05.
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volcanic ash. We co-incubated the cells with the quenching dye 
DQ-OVA that, upon proteolytic processing, allowed us to moni-
tor the endo-lysosomal compartment of living cells. As expected, 
DQ-OVA showed a distinct vesicular distribution in the absence 
of ash. In contrast, ash-treated cells showed enlarged vesicles 
with enhanced particle uptake (Figure  5B). Furthermore, ash 
and DQ-OVA translocated to the cytosol and showed partial co-
localization. Faint fluorescence across the entire cytosol is evident 
of spreading and advanced dilution of the DQ quenching dye.
To test if endosomal uptake was necessary for ash-induced 
cytokine production, we incubated cells with the endocytosis 
inhibitor Lat A prior to ash exposure of the cells and measured 
IL-1β secretion (Figure  5C). Lat A completely inhibited ash-
induced IL-1β release, whereas it had no influence on cytokine 
secretion mediated by the pore-forming toxin nigericin, strength-
ening the role of lysosomal uptake in response to volcanic ash. The 
data further reveal that lysosomal uptake seems to be the main 
uptake mechanism leading to lysosomal rupture with subsequent 
IL-1β release. In terms of lysosomal destabilization, enzymes 
become proteolytically active and are released into cytosol for 
inflammasome activation. Cathepsins are protein-degrading 
enzymes that become cleaved upon lysosomal maturation and 
are released as active forms into the cytosol. The cathepsin family 
comprises multiple proteins involved in IL-1β processing with 
cathepsin B being a well-described player involved in NLRP3 
activation (22, 47). To test the contribution of cathepsins in 
volcanic ash-induced NLRP3 activation, we pre-incubated wild-
type macrophages with the cathepsin B inhibitor CA-074-Me 
prior to ash exposure and measured IL-1β secretion (Figure 5D). 
Inhibition of cathepsin B completely inhibited IL-1β secretion, 
compared to partial effects observed with the lysosomotropic 
agent l-leucyl-l-leucine methyl ester (Leu-Leu-OMe). With 
respect to particulate and non-particulate structures, the data 
further show that, in terms of NLRP3-dependent IL-1β process-
ing, redundant roles of cathepsin family members might play a 
role, as previously described (48).
Particulate substances or fibers are likely candidates for the 
initiation of ROS (19). While ROS are an important feature of 
maintaining immune homeostasis, excessive production results 
in inflammation and carcinogenesis as postulated for inhaled 
asbestos fibers, with mechanisms such as “frustrated” phago-
cytosis being discussed (19, 49, 50). It has been shown that, in 
most scenarios, ROS are associate stimulators of particle-induced 
NLRP3 inflammasome activation. We show here that ROS 
production is involved in ash-induced IL-1β release, using the 
small-molecule ROS scavenger (2R,4R)-4-aminopyrrolidine-2,4-
dicarboxylic acid (APDC), which completely abrogated IL-1β 
secretion (Figure 5E). Previous work has shown that volcanic ash 
has the capacity to generate large amounts of ROS, largely due 
to the presence of non-crystalline-silica minerals (33, 51); how-
ever, the primary non-crystalline-silica components of volcanic 
ash have no history of inducing an inflammatory response (11, 
52). In the present study, we observed low but dose-dependent 
production of IL-1β by the major constituents but, critically, the 
crushed pumice sample, which contains a similar assemblage 
of “non-crystalline-silica minerals,” was minimally reactive. 
Therefore, while auxiliary mineral-based ROS generation may 
be partially implicated in the observed volcanic ash reactivity, 
volcanic cristobalite is the likely candidate for NLRP3-mediated 
IL-1β production by volcanic ash.
DiscUssiOn
There is mounting evidence that, while not overtly toxic, volcanic 
ash exposure can result in general insult with the potential for 
chronic toxicity by inciting a low, but significant, pro-inflamma-
tory response and resulting in delayed inflammation in vivo (10, 
11). In this study, we identify a prominent role for ash-induced 
inflammation, and provide the first mechanism-specific response 
of macrophages to volcanic ash, whereby phagosomal uptake 
results in significant secretion of mature IL-1β. This secretion 
is caspase-1 and ASC dependent, identifying the involvement 
of an inflammasome-mediated pathway. Critically, silencing of 
the murine NLRP3 gene as well as inhibition of human NLRP3 
completely abolished ash-induced IL-1β secretion. We show 
that endocytosis and cathepsins are involved in the induction 
FigUre 5 | Internalization of volcanic ash by macrophages induces lysosomal damage and reactive oxygen species (ROS). (a) Light microscopy (20× 
magnification) and (B) laser scanning microscopy images (63× magnification) of untreated wild-type murine macrophages and macrophages treated with volcanic 
ash sample MRA5/6/99 for 4 h and stained with Ctx B (red) and DQ-Ovalbumin (DQ-OVA) (green). (c–e) LPS-primed immortalized macrophages were stimulated 
with 1 mg/ml MRA5/6/99 in the presence or absence of the endocytosis inhibitor latrunculin A (Lat A) (c), the cathepsin B inhibitor CA-074-Me (D), or the ROS 
scavenger (2R,4R)-4-aminopyrrolidine-2,4-dicarboxylic acid (APDC) (e). Secretion of IL-1β in supernatants was measured by ELISA. Leu-Leu-OMe and nigericin 
served as lysosomotropic positive control and NLRP3-dependent inflammasome activator, respectively. Representative data from two independent experiments are 
shown. *p ≤ 0.05, compared to inhibitors (Lat A, Cath B, APDC).
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of IL-1β secretion, which indicates that lysosomal maturation, 
with subsequent rupture and loss of lysosomal contents into 
the cytosol, is one major mechanism of volcanic ash-induced 
inflammation in  vitro. The NLRP3 inflammasome as an ash-
responsive element appears to be predominantly mediated by 
the crystalline silica phase (cristobalite), although other phases 
induced a low-level response. The componentry of volcanic ash 
is variable and intrinsically linked to eruption history, and, by 
isolating the reactivity of cristobalite, these data provide a new 
avenue for considering the propensity for volcanic ash to incite 
inflammation in order to better constrain the respiratory hazard 
posed during future eruptions.
The exact mechanism of how crystalline structures act on 
inflammasome activation remains elusive. Among others, 
including ROS involvement, discussed are scavenger receptors 
such as the macrophage receptor with collagenous structure 
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(MARCO), CD36, or CD204, with MARCO identified as the 
dominant contributor in the C57BL/6 mouse model (53). 
However, the contribution of these receptors upon silica crystal 
uptake with subsequent IL-1β maturation remains controversial, 
since alveolar macrophages derived from MARCO-null mice 
show increased IL-1β cytokine release (54). Although scavenger 
receptor binding or membrane binding of crystalline particles 
without internalization may also be sufficient for silica-induced 
IL-1β production (55), lysosomal crystal uptake and procession 
is required for a potent inflammatory response. It is well accepted 
that the activation of the NLRP3 inflammasome pathway requires 
two steps: an initial, for example, NF-κB-mediated, priming step 
and a second stimulus for NLRP3 assembly with subsequent 
caspase-1 cleavage. Although we could clearly show that volcanic 
ash is capable of inducing NLRP3 activation in  vitro, a link to 
the initial priming step is still missing. One explanation is 
provided by the fact that ROS seem to act upstream of NLRP3 
activation, involving the NF-κB pathway upon phagocytosis (56, 
57), although ROS are capable of performing both activation and 
inactivation of NF-κB pathways. However, volcanic ash exposure 
rarely occurs in isolation, for example, there will be concomitant 
exposure with anthropogenic pollution in populated regions (58), 
and other phases may initiate signaling. Another priming mecha-
nism was described by Monick et al. (46), involving the ability of 
ash particles to promote bacterial infection by altered pathogen 
killing. This, in turn, would lead to an increased microbial burden 
with enhanced NF-κB signaling (Step 1) via pattern recognition 
receptors and result in a vicious circle.
Chronic inflammation resulting from particle-induced 
inflammasome activation, for example, in silicosis or asbestosis, 
is thought to derive from the inability of cells to destroy the 
ingested material, leading to successive rounds of apoptosis and 
re-ingestion of the crystalline material (4). Volcanic ash (includ-
ing MRA5/6/99), however, has proven to be minimally apoptotic 
and necrotic to macrophages (10, 46), which suggests successful 
clearance of ash from the lungs. The combination of effective 
clearance and inflammasome activation may explain previous 
results from instillation experiments, such as those discussed 
above by Lee and Richards (11), who observed granuloma in the 
lymph nodes followed by considerably delayed lung inflamma-
tion, but no fibrosis. Prompt transport of ash to the lymphatic 
system would preclude an immediate and robust response in situ, 
yet inflammasome-initiated signaling may result in the delayed 
inflammation observed relative to pure crystalline silica. Despite 
this, in the most comprehensive clinical study to date, no hilar 
node enlargement was observed in chest X-rays of 37 children 
on Montserrat who had been exposed to volcanic ash from the 
Soufrière Hills volcano for 10 years (59). Clinical manifestations 
of exposure, therefore, are presently unknown.
The disparity in response between pure-phase cristobalite and 
volcanic ash is attributable, in part, to the heterogeneous nature 
of both the bulk ash (which is ~15 wt.% cristobalite) and the 
ash particles themselves (with individual particles often being 
comprised of various mineral components as seen in Figure 1C). 
However, the extent of this disparity, as also observed in previous 
work (10, 12), suggests that the reactivity of volcanic cristobalite 
itself is suppressed. Crystalline silica reactivity may be contingent 
on fracturing the surfaces of crystals in equilibrium (60). The 
high-energy nature of ash generation, through both explosive 
eruptions and dome-collapse events, ensures that volcanic cris-
tobalite surfaces will be readily and commonly fractured. Nano-
scale chemical and structural investigations of surface-exposed 
cristobalite crystals reveal no evidence for occlusion (8), and the 
presence of a reactive cristobalite surface has been implicated 
in the binding of similar proteins by cristobalite-rich volcanic 
ash and a crystalline silica standard (61). Therefore, intrinsic 
modifications may act to suppress volcanic cristobalite reactivity 
beyond the aforementioned diminished surface area-dose, as pre-
viously postulated (8, 14). In particular, all volcanic cristobalite 
is chemically impure, containing up to 3 wt.% aluminum (7, 8); 
incorporation of structural aluminum at an equivalent dopant 
concentration has been shown to suppress cristobalite reactiv-
ity (15), and may affect the presence of certain surface moieties 
(i.e., silanols) deemed critical for crystalline silica reactivity (62). 
Critically, however, volcanic cristobalite appears to be sufficiently 
reactive to have initiated a response here.
Significant advances in our understanding of the hazard 
posed by volcanic ash have been made in recent years; however, 
a serious concern regarding the crystalline silica polymorph 
cristobalite, the only toxic mineral phase appreciably present in 
volcanic ash, has persisted. The observations presented herein 
confirm adherence to the “variable entity” description of crystal-
line silica, as defined for quartz by Donaldson and Borm (13) and 
considered for volcanic cristobalite by Horwell et al. (8), whereby 
the reactive-silica burden for volcanic cristobalite is insufficient 
to initiate the more immediate and robust response observed with 
pure crystalline silica. As discussed, previously reported chemical 
and structural modifications have been hypothesized to alter the 
pathogenicity of volcanic cristobalite relative to a pure-phase 
standard (8). We show here, for the first time, that these modi-
fications are insufficient to abrogate reactivity completely. With 
the potential for volcanic eruptions to impact millions of people, 
and with so few epidemiological studies having been conducted, 
mechanistic insight into the potential for ash to cause disease is 
of immediate public health value. Identification of an established 
pathway involved in other particle-induced diseases and through 
which volcanic ash can induce a chronic inflammatory response 
offers a foundation on which to provide health risk assessments 
during future volcanic crises.
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